1. Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis.
- Author
-
Bessar H, Venditti I, Benassi L, Vaschieri C, Azzoni P, Pellacani G, Magnoni C, Botti E, Casagrande V, Federici M, Costanzo A, Fontana L, Testa G, Mostafa FF, Ibrahim SA, Russo MV, and Fratoddi I
- Subjects
- Administration, Cutaneous, Animals, Cell Survival drug effects, Cells, Cultured, Dermatologic Agents administration & dosage, Dermatologic Agents chemistry, Dermatologic Agents pharmacology, Drug Liberation, Humans, Hydrophobic and Hydrophilic Interactions, Keratinocytes drug effects, Keratinocytes metabolism, Keratinocytes ultrastructure, Methotrexate chemistry, Methotrexate pharmacokinetics, Mice, Inbred C57BL, Microscopy, Electron, Transmission, Skin metabolism, Skin Absorption, Spectrophotometry, Spectroscopy, Fourier Transform Infrared, Gold chemistry, Metal Nanoparticles chemistry, Methotrexate pharmacology, Psoriasis drug therapy, Sulfhydryl Compounds chemistry
- Abstract
Gold nanoparticles (AuNPs) represent an effective choice for topical drug delivery systems thanks to their small size, general non-toxicity, ease of functionalization and high surface to volume ratio. Even if systemic, methotrexate still plays an important role in psoriasis treatment: its topical use shows insufficient percutaneus penetration owing to limited passive diffusion, high molecular weight and dissociation at physiological pH. The aim of our study was to design a new drug delivery nanocarrier for Methotrexate and to improve its solubility, stability and biodistribution. AuNPs were on purpose prepared with a hydrophilic stabilizing layer, in order to improve the colloidal stability in water. Water-soluble gold nanoparticles functionalized by sodium 3-mercapto-1-propansulfonate (Au-3MPS) were prepared and loaded with methotrexate (MTX). The loading efficiency of MTX on Au-3MPS was assessed in the range 70-80%, with a fast release (80% in one hour). The release was studied up to 24h reaching the value of 95%. The Au-3MPS@MTX conjugate was fully characterized by spectroscopic techniques (UV-vis, FTIR) and DLS. Preliminary toxicity tests in the presence of keratinocytes monolayers allowed to assess that the used Au-3MPS are not toxic. The conjugate was then topically used on C57BL/6 mouse normal skin in order to trace the absorption behavior. STEM images clearly revealed the distribution of gold nanoparticles inside the cells. In vitro studies showed that Methotrexate conjugated with Au-3MPS is much more efficient than Methotrexate alone. Moreover, DL50, based on MTT analysis, is 20 folds reduced at 48 h, by the presence of nanoparticles conjugation. UV-vis spectra for in vivo tracing of the conjugate on bare mouse skin after 24h of application, show increased delivery of Methotrexate in the epidermis and dermis using Au-3MPS@MTX conjugate, compared to MTX alone. Moreover we observed absence of the Au-3MPS in the dermis and in the epidermis, suggesting that these layers of the skin do not retain the nanoparticles. Based on our data, we found that the novel Au-3MPS@MTX conjugate is an effective non-toxic carrier for the satisfactory percutaneous absorption of Methotrexate and could help in possible topical treatment of psoriasis., (Copyright © 2016 Elsevier B.V. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF